Zhou Y - Search Results

1

Integrative Analysis of the Predictive Value of Perilipin Family on Clinical Significance, Prognosis and Immunotherapy of Glioma.

Li X, Kang K, Shen L, Shen L, Zhou Y. Li X, et al. Among authors: zhou y. Biomedicines. 2023 Mar 24;11(4):1009. doi: 10.3390/biomedicines11041009. Biomedicines. 2023. PMID: 37189627 Free PMC article.

2

Methylation of PAX1 gene promoter in the prediction of concurrent chemo-radiotherapy efficacy in cervical cancer.

Li X, Zhou X, Zeng M, Zhou Y, Zhang Y, Liou YL, Zhu H. Li X, et al. Among authors: zhou x, zhou y. J Cancer. 2021 Jun 22;12(17):5136-5143. doi: 10.7150/jca.57460. eCollection 2021. J Cancer. 2021. PMID: 34335930 Free PMC article.

3

Identification and validation of a tyrosine metabolism-related prognostic prediction model and characterization of the tumor microenvironment infiltration in hepatocellular carcinoma.

Zhou Y, Li X, Long G, Tao Y, Zhou L, Tang J. Zhou Y, et al. Among authors: zhou l. Front Immunol. 2022 Oct 20;13:994259. doi: 10.3389/fimmu.2022.994259. eCollection 2022. Front Immunol. 2022. PMID: 36341373 Free PMC article.

4

Comprehensive analysis of the expression profile and clinical implications of regulator of chromosome condensation 2 in pan-cancers.

Li X, Kang K, Peng Y, Shen L, Shen L, Zhou Y. Li X, et al. Among authors: zhou y. Aging (Albany NY). 2022 Nov 27;14(22):9221-9242. doi: 10.18632/aging.204403. Epub 2022 Nov 27. Aging (Albany NY). 2022. PMID: 36441563 Free PMC article.

5

PAX1 hypomethylation as a prognostic biomarker for radioresistance of cervical cancer.

Li X, Liu H, Zhou X, Zhou Y, Zhang Y, Liou YL, Zeng M, Zhu H. Li X, et al. Among authors: zhou x, zhou y. Clin Epigenetics. 2023 Aug 2;15(1):123. doi: 10.1186/s13148-023-01538-1. Clin Epigenetics. 2023. PMID: 37533109 Free PMC article.

6

The deubiquitinase EIF3H promotes hepatocellular carcinoma progression by stabilizing OGT and inhibiting ferroptosis.

Tang J, Long G, Li X, Zhou L, Zhou Y, Wu Z. Tang J, et al. Among authors: zhou y, zhou l. Cell Commun Signal. 2023 Aug 9;21(1):198. doi: 10.1186/s12964-023-01220-2. Cell Commun Signal. 2023. PMID: 37559097 Free PMC article.

7

AP4M1 as a prognostic biomarker associated with cell proliferation, migration and immune regulation in hepatocellular carcinoma.

Peng Y, Li X, Kang K, Zhou Y. Peng Y, et al. Among authors: zhou y. Cancer Cell Int. 2023 Oct 11;23(1):235. doi: 10.1186/s12935-023-03089-0. Cancer Cell Int. 2023. PMID: 37821948 Free PMC article.

8

Comprehensive Analysis of Disulfidptosis-Related LncRNAs in Molecular Classification, Immune Microenvironment Characterization and Prognosis of Gastric Cancer.

Kang K, Li X, Peng Y, Zhou Y. Kang K, et al. Among authors: zhou y. Biomedicines. 2023 Nov 28;11(12):3165. doi: 10.3390/biomedicines11123165. Biomedicines. 2023. PMID: 38137387 Free PMC article.

9

Integrative analysis of multiple cell death model for precise prognosis and drug response prediction in gastric cancer.

Su W, Shi X, Wen X, Li X, Zhou J, Zhou Y, Ren F, Kang K. Su W, et al. Among authors: zhou y, zhou j. Discov Oncol. 2024 Oct 8;15(1):532. doi: 10.1007/s12672-024-01411-4. Discov Oncol. 2024. PMID: 39377861 Free PMC article.

10

The deubiquitinating enzyme ATXN3 promotes hepatocellular carcinoma progression by stabilizing TAZ.

Peng Y, Nie H, Kang K, Li X, Tao Y, Zhou Y. Peng Y, et al. Among authors: zhou y. Cancer Gene Ther. 2024 Dec 13. doi: 10.1038/s41417-024-00869-2. Online ahead of print. Cancer Gene Ther. 2024. PMID: 39672915

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73,620 results

Search Page

Filters